Delivery Order SPE2DB20D1050-SPE2DB25FH65K
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,270.30 on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, identified as COMIRNATY 2024-25 (12 years and up) at 0.3 milliliters, represents a single-dose vaccine supply for military healthcare operations. The contract was competitively awarded with no set-aside provisions and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $3,810.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2024-25 vaccine product (12 years and up, 0.3 mL syringes) with an ultimate completion date of June 3, 2025. This competitively awarded, non-set-aside contract was issued on June 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a $12,703.00 delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2024-25 vaccine doses (0.3mL syringes for ages 12 and up). This non-set-aside, competitively awarded contract features firm fixed price terms with an ultimate completion date of April 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and performs the work at its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,893.18 to AmerisourceBergen Drug Corp for Comirnaty 2025-26 vaccine (12-year and older formulation, 0.3 mL syringes) with a completion date of October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12 years and up, 0.3mL syringes) with a ceiling value of $1,893.18 and an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through...
- The Defense Logistics Agency awarded a delivery order valued at $1,270.30 to AmerisourceBergen Drug Corp for Comirnaty 2024-25 vaccine (12 years and up, 0.3mL syringes) with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, issued on August 18, 2025, carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency awarded a $10,060.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12 years and up, 0.3mL syringes) with an ultimate completion date of November 6, 2025. This is a non-set-aside competitive award issued on October 16, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12 years and older, 0.3mL syringes) with a ceiling value of approximately $20.2K. This competitively awarded, non-set-aside contract was issued on September 29, 2025, with an ultimate completion date of September 30, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract employs firm fixed-price pricing and represents a delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,262.12 for Comirnaty 2025-26 (12 years and up) in 0.3 mL syringes, with an ultimate completion date of October 16, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the prime contractor at its Conshohocken, Pennsylvania location. The award represents a continuation of pharmaceutical supply deliveries under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,175.75 on July 8, 2025, for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3 mL syringes. This firm fixed-price delivery order, which was not set aside for small business, is scheduled for completion by July 9, 2025, with performance at the awardee's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's larger Indefinite...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH65KDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,175.75 to AmerisourceBergen Drug Corp for COMIRNATY 2024-25 (12 years and up) vaccine in 0.3 mL syringes, with an ultimate completion date of May 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under DLA's medical supply chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support platform enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's status as a major pharmaceutical distributor and established federal vendor demonstrates its capability to meet DLA's medical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 5/6/25 |